Identified Risk Factors for Duchenne Muscular Dystrophy

Both Dr. Mammen and Dr. Olson have been able to successfully edit DMD genes that encode a protein called dystrophin in human cells. Nowadays, and according to the findings provided by previous studies, they will start working on trials for human beings. They both believe that this technique can result in the first successful genome used to edit human genes to prevent Duchenne muscular dystrophy, which is considered a fatal disease.